• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDELA LLC PNSA STARTER BP EN ES USA; PUMP, BREAST, POWERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDELA LLC PNSA STARTER BP EN ES USA; PUMP, BREAST, POWERED Back to Search Results
Model Number 101035077
Health Effect - Clinical Code Unspecified Infection (1930)
Date of Event 10/01/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Customer service conducted troubleshooting with the customer, including inspecting the faceplate and back plate for damage; inspecting and cleaning the diaphragm; disassembling, inspecting, cleaning and reassembling the kit and tubing set; and verifying breast shield fit.Following troubleshooting, the customer indicated that the troubleshooting did not resolve the issue.A replacement device was sent to the customer.The customer was contacted by a complaint handler to get additional information, with no response as of the date of this report.Based on the results of (b)(4), it cannot be definitively concluded that the pump caused or contributed to the customer's mastitis.The estimated incidence of mastitis in lactating women, whether using a breast pump or not, according to published clinical literature can be as high as 33%.In fact, clinical guidelines suggest the use of a breast pump to facilitate withdrawal of breast milk during bouts of mastitis.The complaint rate of mastitis across all reported failures, across all medela breast pumps, is 0.008% for the period of january 2013 to august 2017.Mastitis is usually a benign, self-limiting infection with few consequences for the suckling infant.The risk of mastitis is higher among women who have breastfed previously, especially those with a history or mastitis." riordan & wambach, 4th ed.P.294: breastfeeding and human lactation.Mastitis requires prompt medical attention for the mother for pain relief and prescription antibiotics to avoid progression to overwhelming sepsis.
 
Event or Problem Description
On (b)(6) 2021 the customer alleged that when using her pump in style breast pump she has to increase the suction to the maximum level while in the first phase to get suction but decrease the suction when she is in the second phase.She also alleged that she had clogged ducts and mastitis back in (b)(6) and was prescribed an antibiotic.She also indicated that she has used another pump in style breast pump and it has a performance that this pump does not have.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PNSA STARTER BP EN ES USA
Common Device Name
PUMP, BREAST, POWERED
Manufacturer (Section D)
MEDELA LLC
1101 corporate dr
mchenry, il
MDR Report Key11338841
Report Number1419937-2021-00012
Device Sequence Number11441398
Product Code HGX
UDI-Device Identifier00020451350776
UDI-Public020451350776
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K181937
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source consumer
Initial Reporter Occupation Other
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model Number101035077
Device Catalogue Number101035077
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/03/2021
Initial Report FDA Received Date02/17/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-